Navigation Links
Webcast Alert: Isis Pharmaceuticals Hosts Expert Panel Conference Call to Discuss Mipomersen Data Presented at the ESC Congress 2010
Date:8/30/2010

CARLSBAD, Calif., Aug. 30 /PRNewswire-FirstCall/ -- Isis Pharmaceuticals, Inc. (Nasdaq: ISIS) announces the following webcast:What:

Data from mipomersen Phase 3 trial in heFH patients presented at ESCWhen:

Wednesday, September 1, 2010 at 4:00 p.m. ET / 1:00 p.m. PTWhere:

www.isispharm.comHow:

Live on the Internet.  Simply log onto our Web site listed above. If you are unable to participate during the live event, a replay of the webcast will be available for a limited time at www.isispharm.com.

ABOUT ISIS PHARMACEUTICALS, INC.Isis is exploiting its expertise in RNA to discover and develop novel drugs for its product pipeline and for its partners.  The Company has successfully commercialized the world's first antisense drug and has 23 drugs in development.  Isis' drug development programs are focused on treating cardiovascular, metabolic, and severe neurodegenerative diseases and cancer.  Isis' partners are developing antisense drugs invented by Isis to treat a wide variety of diseases.  Isis and Alnylam Pharmaceuticals are joint owners of Regulus Therapeutics Inc., a company focused on the discovery, development and commercialization of microRNA therapeutics.  Isis also has made significant innovations beyond human therapeutics resulting in products that other companies, including Abbott, are commercializing.  As an innovator in RNA-based drug discovery and development, Isis is the owner or exclusive licensee of over 1,600 issued patents worldwide.  Additional information about Isis is available at www.isispharm.com.


'/>"/>

SOURCE Isis Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Advanced Life Sciences to Host Second Quarter 2010 Conference Call and Live Webcast
2. Volcano Corporation Presentation at Canaccord Genuity Growth Conference to be Webcast
3. Medivation Announces Second Quarter 2010 Financial Results Teleconference and Webcast on August 9, 2010
4. Orexigen® Therapeutics Schedules August 5, 2010 Webcast Discussion of Financial Results for the Second Quarter Ended June 30, 2010
5. Amicus Therapeutics to Host Its Second Quarter 2010 Financial Results Conference Call and Webcast on August 5, 2010
6. Onyx Pharmaceuticals Announces a Teleconference and Webcast to Provide a Clinical Update on Carfilzomib
7. Thoratec Schedules Second Quarter Conference Call, Webcast
8. Neurocrine Biosciences Announces Conference Call and Webcast to Report Second Quarter 2010 Financial Results
9. Kendle Announces Details Regarding Second Quarter 2010 Earnings Conference Call and Webcast
10. Mylan Schedules Second Quarter 2010 Financial Results Conference Call and Live Webcast
11. Watson to Host Conference Call and Webcast to Discuss Second Quarter 2010 Earnings
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2016)... 2016 --> ... "Pharmaceutical Packaging Equipment Market by Package Type (Blister, Strip, ... Product Type (Tablet, Powder, Cream, Syrup, Aseptic Liquid, Aerosol) ... global market during the forecast period of 2015 to ... CAGR of 6.9% during the forecast period to reach ...
(Date:2/10/2016)... aims to ensure 2,50,532 children between the ages ... th birthday   --> The campaign ... - 5 years reach the milestone of their 5 ... aims to ensure 2,50,532 children between the ages of 2 ... birthday   India , have launched the "Joy of Five" ...
(Date:2/9/2016)...  Insulet Corporation (NASDAQ: PODD ) (Insulet or the ... with its OmniPod ® Insulin Management System, ... appointed to Insulet,s Board of Directors. With his appointment, the ... are independent. --> --> ... experience and a deep knowledge of accounting, financial reporting and ...
Breaking Medicine Technology:
(Date:2/10/2016)... ... ... For additional information contact Phyllis Strupp 480-488-5858 , Brain improves with age, says ... to Brain Training" by award-winning author Phyllis Strupp explains how brain exercise ... 2016. A free review copy is available to the media at NetGalley . ...
(Date:2/10/2016)... ... February 10, 2016 , ... Everseat has joined the ... available to physicians. The integration will enable Allscripts users to post open appointments ... free mobile app. , The partnership gives Everseat substantial added power to help ...
(Date:2/10/2016)... ... February 10, 2016 , ... Workrite Ergonomics this week announced the launch ... mounts ever. , “Our goal was to develop a product from the ground ... we have ever created.” said Darren Hulsey, Product Manager for Workrite Ergonomics. “The ...
(Date:2/10/2016)... ... 2016 , ... Anxiety of older Americans over steep cost increases of prescription ... decade ago, according to The Senior Citizens League (TSCL). Since last ... with rapidly rising costs. “The implications are chilling, particularly for people with chronic ...
(Date:2/10/2016)... , ... February 09, 2016 , ... ... Clevens Face and Body Specialists are delighted to welcome a new addition to ... Clevens Face and Body Specialists as a nurse practitioner performing cosmetic procedures ...
Breaking Medicine News(10 mins):